These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 34009568)
1. Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents. Kucuk B; Yilmaz E; Cacan E Mol Biol Rep; 2021 May; 48(5):3999-4008. PubMed ID: 34009568 [TBL] [Abstract][Full Text] [Related]
2. Expressional regulation of NKG2DLs is associated with the tumor development and shortened overall survival in lung adenocarcinoma. Kucuk B; Cacan E Immunobiology; 2022 Jul; 227(4):152239. PubMed ID: 35780757 [TBL] [Abstract][Full Text] [Related]
4. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA. Kim Y; Born C; Bléry M; Steinle A Front Immunol; 2020; 11():960. PubMed ID: 32582150 [TBL] [Abstract][Full Text] [Related]
5. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition. Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870 [TBL] [Abstract][Full Text] [Related]
6. NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma. Wang T; Sun F; Wang Y; Jiang J; Pan M; Yuan M; Zhang H; Du X; Hezam K; Song K; Wang M; Zhang J J Immunother; 2018 Apr; 41(3):109-117. PubMed ID: 29528990 [TBL] [Abstract][Full Text] [Related]
7. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma. Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020 [TBL] [Abstract][Full Text] [Related]
9. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924 [TBL] [Abstract][Full Text] [Related]
10. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
11. miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA. Tang S; Fu H; Xu Q; Zhou Y Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 30988067 [TBL] [Abstract][Full Text] [Related]
12. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Salih HR; Antropius H; Gieseke F; Lutz SZ; Kanz L; Rammensee HG; Steinle A Blood; 2003 Aug; 102(4):1389-96. PubMed ID: 12714493 [TBL] [Abstract][Full Text] [Related]
13. Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing. Vulpis E; Loconte L; Cassone C; Antonangeli F; Caracciolo G; Masuelli L; Fazio F; Petrucci MT; Fionda C; Soriani A; Cerboni C; Cippitelli M; Santoni A; Zingoni A Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298418 [TBL] [Abstract][Full Text] [Related]
14. Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer. Espinoza I; Agarwal S; Sakiyama M; Shenoy V; Orr WS; Diffalha SA; Prizment A; Varambally S; Manne U; Gomez CR Front Biosci (Landmark Ed); 2021 Oct; 26(10):765-776. PubMed ID: 34719204 [No Abstract] [Full Text] [Related]
15. Rae1 drives NKG2D binding-dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells. Zhao P; Yang L; Li X; Lu W; Lu F; Wang S; Wang Y; Hua L; Cui C; Dong B; Yu Y; Wang L Cancer Sci; 2020 Jul; 111(7):2234-2247. PubMed ID: 32333709 [TBL] [Abstract][Full Text] [Related]
16. Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy. Ding H; Yang X; Wei Y Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316666 [TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914 [TBL] [Abstract][Full Text] [Related]
18. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor. Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792 [TBL] [Abstract][Full Text] [Related]
19. Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway. Zhu Y; Zhao Z; Xue M; Wang D; Su G; Ju X; Yang Q; Zhang S; Fan D; Zhu H; Yu M; Li Y; Kong L; Zhou H Biochem Biophys Res Commun; 2023 Jun; 659():10-19. PubMed ID: 37030020 [TBL] [Abstract][Full Text] [Related]